Literature DB >> 25432723

Medical and surgical treatment of tremors.

Susanne A Schneider1, Günther Deuschl2.   

Abstract

Tremor is a hyperkinetic movement disorder characterized by rhythmic oscillations of one or more body parts. Disease severity ranges from mild to severe with various degrees of impact on quality of life. Essential tremor and parkinsonian tremor are the most common etiologic subtypes. Treatment may be challenging; although several drugs are available, response may be unsatisfactory. For some tremor forms, controlled data are scarce or completely missing and treatment is often based on anecdotal evidence. In this article, we review the current literature on tremor treatment, with a focus on common forms.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Beta blocker; Deep brain stimulation; Dystonic tremor; Essential tremor; Primidone; Topiramate; Tremor

Mesh:

Substances:

Year:  2015        PMID: 25432723     DOI: 10.1016/j.ncl.2014.09.005

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  4 in total

1.  Essential tremor.

Authors:  Theresa Ann Zesiewicz; Sheng-Han Kuo
Journal:  BMJ Clin Evid       Date:  2015-12-15

2.  Approach to a tremor patient.

Authors:  Soumya Sharma; Sanjay Pandey
Journal:  Ann Indian Acad Neurol       Date:  2016 Oct-Dec       Impact factor: 1.383

3.  Clinical Outcome and Characterization of Local Field Potentials in Holmes Tremor Treated with Pallidal Deep Brain Stimulation.

Authors:  Adolfo Ramirez-Zamora; Brian C Kaszuba; Lucy Gee; Julia Prusik; Fabio Danisi; Damian Shin; Julie G Pilitsis
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-06-30

4.  Novel Functional MRI Task for Studying the Neural Correlates of Upper Limb Tremor.

Authors:  Frederique M C Boonstra; Thushara Perera; Gustavo Noffs; Cassandra Marotta; Adam P Vogel; Andrew H Evans; Helmut Butzkueven; Bradford A Moffat; Anneke van der Walt; Scott C Kolbe
Journal:  Front Neurol       Date:  2018-07-02       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.